Published November 2021
| Version v1
Journal article
Single Application Multifractionated Image Guided Adaptive High-Dose-Rate Brachytherapy for Cervical Cancer: Dosimetric and Clinical Outcomes
Creators
- 1. Department of Radiation Oncology & Medical Physics, Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam (India)
- 2. Department of Radiation Oncology & Medical Physics, Tata Memorial Hospital, Homi Bhabha National Institute (HBNI), Mumbai (India)
- 3. Department of Radiation Oncology, NCI, Nagpur (India)
Description
A prospective phase 2 study was conducted to evaluate the feasibility and safety of single-application multifractionated (SA-MF), high-dose-rate (HDR), image guided adaptive brachytherapy (IGABT) for cervical cancer.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2021.06.014Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2021.06.014;
- PII
- S036030162100732X;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 111
- Journal Issue
- 3
- Journal Page Range
- p. 826-834
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53124665
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRACHYTHERAPY; DOSE RATES; IMAGES; NEOPLASMS; SAFETY
- Descriptors DEC
- DISEASES; MEDICINE; NUCLEAR MEDICINE; RADIOLOGY; RADIOTHERAPY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2021 Elsevier Inc. All rights reserved.